# OnCo record intreall-sr-2010 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/intreall-sr-2010/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "intreall-sr-2010", "NCT01802814" ;
  schema:name "IntReALL SR 2010"@en ;
  schema:alternateName "IntReALL"@en, "IntReALL 2010"@en ;
  schema:description "IntReALL SR 2010 brought the European relapse groups together to compare their two chemotherapy programmes head to head for children whose leukaemia had returned, and to test adding an antibody against CD22; it has completed and the corpus records the design while the full results are awaited."@en ;
  schema:url <https://onco.cc/trials/intreall-sr-2010/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01802814> ;
  onco:status "completed" ;
  onco:tag "soc-trials" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/all-paediatric-relapsed/>, <https://onco.cc/cancers/all-leukemia/>, <https://onco.cc/cancers/leukaemia/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/>, <https://onco.cc/drugs/mitoxantrone/> ;
  onco:institutions <https://onco.cc/institutions/charite/> .